CBIO
Crescent Biopharma, Inc.
14.30$
+0.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -13.49 | -11.83 | -16.30 | -13.79 | -12.40 | -5.74 | -14.06 | -4.25 | -1.06 | -1.33 | -0.29 | -0.64 | -2.38 | |
| 0.07 | 0.04 | 0.02 | 0.02 | 0.01 | 54.49 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | |
| 1.38 | 1.47 | 1.91 | 1.93 | 1.76 | 1.80 | 1.59 | 1.38 | 0.12 | 0.24 | 0.14 | 0.13 | 0.49 | |
| -0.99 | 0.47 | -1.84 | -0.36 | 0.28 | 3.71 | 3.97 | -0.56 | 0.30 | -0.95 | 0.33 | 0.10 | -0.04 | |
| 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.04 | 3.58 | 0.27 | 0.00 | 2.65 | |
| -0.01 | 0.00 | -0.01 | 0.00 | 0.02 | 0.05 | – | -0.04 | -0.04 | -3.58 | -0.27 | 0.06 | -2.59 | |
| – | – | – | – | – | 0.00 | – | -0.05 | – | 0.01 | – | – | – | |
| – | – | – | – | – | 58.12 | – | – | – | – | – | – | – | |
| 0.10 | 0.00 | 0.01 | 0.00 | -0.01 | 63.64 | -1.93 | 38.08 | -0.08 | 8.87 | -0.23 | 0.00 | 5.59 | |
| -13.41 | -11.83 | -16.31 | -13.79 | -12.40 | -5.69 | -15.98 | 33.79 | -1.17 | 3.96 | -0.79 | -0.58 | 0.62 | |
| -13.51 | -11.83 | -16.32 | -13.80 | -12.40 | -5.74 | -14.06 | -4.29 | -1.10 | -4.90 | -0.56 | -0.64 | -5.03 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.